Journal Article10.1016/S0968-0004(97)01155-9
A good antisense molecule is hard to find
TL;DR: To minimize unwanted non-antisense effects, investigators are searching for antisense compounds and ribozymes whose target sites are particularly vulnerable to attack.
read more
About: This article is published in Trends in Biochemical Sciences. The article was published on 01 Feb 1998.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Patent
Methods and products for manipulating uncoupling protein expression
Martha Karen Newell
- 22 Jun 2000
TL;DR: In this paper, it was shown that uncoupling proteins (UCPs) are expressed in the plasma membrane of rapidly dividing cells but not of growth arrested, chemotherapy resistant cells.
21
Patent
Specific inhibitors of DNA methyl transferase
Moshe Szyf,Pascal Bigey +1 more
- 08 Dec 1998
TL;DR: The mechanism-based inhibitors of DNA methyltransferase enzyme, and diagnostic and therapeutic uses for the same, are described in this paper, which form stable, noncovalent complexes with DNA methyl transferase enzyme in a manner which is independent of S-adenosylmethionine.
21
•Journal Article
Anti-IgE and other new immunomodulation-based therapies for allergic asthma.
R. E. Jonkers,J. S. Van Der Zee +1 more
TL;DR: Treatment with omalizumab was associated with moderate improvements in a number of relevant endpoints, including the rate of occurrence of disease exacerbations, and newer DNA-based therapeutic strategies including DNA vaccination and the antisense oligonucleotides show promise but thus far have only been tested in animal models.
Patent
Retroviral hybrid vectors pseudotyped with LCMV
Meike-Dorothee Von Laer,Winfried Beyer +1 more
- 11 May 1999
TL;DR: In this article, the authors proposed a pseudotyping of retroviruses with lymphocytic choriomeningitis virus (LCMV) packaging cells which are optionally env-deleted, or in packaging cells derived from lentiviruses.
21
Patent
Antisense modulation of glioma-associated oncogene-2 expression
Frank C. Bennett,Susan M. Freier +1 more
- 07 Sep 2001
TL;DR: Antisense compounds, compositions and methods for modulating the expression of glioma-associated oncogene-1 are provided in this article, where the compositions comprise antisense compounds particularly antisense oligonucleotides, targeted to nucleic acids encoding Glioma associated oncogen-1.
21
References
Quantitative monitoring of gene expression patterns with a complementary DNA microarray.
TL;DR: A high-capacity system was developed to monitor the expression of many genes in parallel by means of simultaneous, two-color fluorescence hybridization, which enabled detection of rare transcripts in probe mixtures derived from 2 micrograms of total cellular messenger RNA.
10.9K
Cpg motifs in bacterial dna trigger direct b-cell activation
Arthur M. Krieg,Ae-Kyung Yi,Sara Matson,Thomas J. Waldschmidt,Gail A. Bishop,Gail A. Bishop,Rebecca M. Teasdale,Gary A. Koretzky,Dennis M. Klinman +8 more
TL;DR: The potent immune activation by CpG oligon nucleotides has impli-cations for the design and interpretation of studies using 'antisense' oligonucleotides and points to possible new applications as adjuvants.
3.9K
Antisense oligonucleotides as therapeutic agents--is the bullet really magical?
Cy A. Stein,Yung-Chi Cheng +1 more
TL;DR: The potential use of phosphorothioate oligos as inhibitors of viral replication is highlighted and these are examples of oligos that are being considered for clinical therapeutic trials and meet some, but not all, of these criteria.
1.5K
Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C- raf kinase
TL;DR: It is suggested that antisense inhibitors targeted against C–raf–1 kinase may be of considerable value as antineoplastic agents that display activity against a wide spectrum of tumor types at well–tolerated doses.
511
Selecting effective antisense reagents on combinatorial oligonucleotide arrays.
TL;DR: An array of 1,938 oligodeoxynucleotides was fabricated on the surface of a glass plate and used to measure the potential of oligonucleotide for heteroduplex formation with rabbit β-globin mRNA, finding no obvious features in the mRNA sequence or the predicted secondary structure that can explain the variation in heterod uplex yield.
404